EPO Patents = 1

Forward Citations = 0

Loading Chart...

10 inventors (with patents filed for the assignee):

Dae Ho Cho (5 out of 12 patents)

Sun Young Park (4 out of 94 patents)

Kyung Eun Kim (4 out of 6 patents)

4. Myun Soo Kim (3 out of 4 patents)

5. Hee Young Jung (2 out of 2 patents)

6. Min Chan Gil (1 out of 2 patents)

7. So Mi Lee (1 out of 2 patents)

8. Youn Kyung Houh (1 out of 2 patents)

9. Joo Hyun Lee (1 out of 2 patents)

10. Myung Jin Jung (1 out of 40 patents)

5 patents: Sort by Forward Citations

1. 11730788 - Use of peptides as therapeutic agent for autoimmune diseases and bone diseases (2023-08-22),

2. 11629169 - Use of peptides as therapeutic agent for autoimmune diseases and bone diseases (2023-04-18),

3. 10995117 - Peptide for skin regeneration or wound treatment and use thereof (2021-05-04),

4. 10913772 - Peptide for preventing or treating inflammatory diseases and use thereof (2021-02-09),

5. 10913771 - Peptide for preventing or treating inflammatory diseases and use thereof (2021-02-09),

Company Overview

Kine Sciences Co., Ltd. is a leading biotechnology company specializing in the research, development, and production of innovative medical solutions for various health conditions. With a focus on personalized medicine, Kine Sciences is dedicated to improving patient outcomes through cutting-edge technology and scientific expertise.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

5 Patents

#672 in Seoul

#1,881 in South Korea

Seoul, South Korea

Kine Sciences Co., Ltd.

Forward Citations = 0

10 inventors:

Dae Ho Cho (5 out of 12 patents)

Sun Young Park (4 out of 94 patents)

Kyung Eun Kim (4 out of 6 patents)

4. Myun Soo Kim (3 out of 4 patents)

5. Hee Young Jung (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Kine Sciences Co., Ltd.. Retrieved from https://idiyas.com/company/kine-sciences-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]